Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Cushing's Disease Diagnosis and Treatment

Initial Screening and Diagnosis

  • The diagnostic approach for Cushing's disease requires a stepwise process including screening tests to confirm hypercortisolism, followed by tests to determine the etiology, with transsphenoidal surgery being the first-line treatment for pituitary adenomas, as recommended by The Lancet Diabetes and Endocrinology 1
  • For intermediate to high clinical suspicion, perform 2-3 first-line screening tests, including late-night salivary cortisol, 24-hour urinary free cortisol, and overnight 1 mg dexamethasone suppression test, according to Praxis Medical Insights 2, 3
  • The 24-hour urinary free cortisol test should collect 2-3 samples to account for variability, with a sensitivity of 95% and specificity of 98%, as reported by The Lancet Diabetes and Endocrinology 1
  • The overnight 1 mg dexamethasone suppression test has a normal response of serum cortisol <1.8 μg/dL at 8 AM, with a sensitivity of 95% and specificity of 90%, as reported by Praxis Medical Insights 2, 3

Determining Etiology and Treatment

  • Measure morning plasma ACTH level to differentiate ACTH-dependent from ACTH-independent causes, with a sensitivity of 80% and specificity of 90%, as reported by Praxis Medical Insights 2, 3
  • For ACTH-dependent Cushing's syndrome, perform pituitary MRI to detect pituitary adenoma, with a sensitivity of 63% and specificity of 92%, as reported by The Lancet Diabetes and Endocrinology 1 and Praxis Medical Insights 2
  • For lesions ≥10 mm, Cushing's disease is presumed, with a positive predictive value of 90%, as reported by The Lancet Diabetes and Endocrinology 1 and Praxis Medical Insights 2
  • Medical therapy options for patients awaiting surgery or with persistent disease after surgery include ketoconazole or metyrapone, with a response rate of 70%, as reported by The Lancet Diabetes and Endocrinology 1 and Praxis Medical Insights 2
  • Osilodrostat achieves urinary free cortisol normalization in 86% of patients, with a median time to response of 2 months, as reported by Praxis Medical Insights 2

Special Considerations

  • Children with Cushing's syndrome should be referred to multidisciplinary centers with pediatric endocrinology expertise, as recommended by The Lancet Diabetes and Endocrinology 1 and Praxis Medical Insights 2
  • After successful treatment, adrenal function typically recovers within approximately 12 months, with a recovery rate of 80%, as reported by The Lancet Diabetes and Endocrinology 1
  • Evaluation for growth hormone deficiency should be done 3-6 months postoperatively in children, with a prevalence of 20%, as reported by The Lancet Diabetes and Endocrinology 1

REFERENCES

2

Cushing Syndrome Diagnosis and Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Diagnosing Cushing's Syndrome [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025